Study Results
A total of 3896 studies were identified through four database searches and an additional 12 studies were identified through reference lists, resulting in the selection of 3907 articles for review. After removing 1029 duplicate studies, the title and abstract of the remaining 2828 studies were reviewed. 2,652 studies were excluded because they looked at the wrong people, results, and subjects. The 82 articles were reviews, research reports, letters or editorials. Of the remaining 144 articles that were reviewed in full, 123 studies were excluded. The reasons for exclusion were that 79 studies did not use validated fatigue assessment tools, 27 studies did not provide data on the prevalence of fatigue, 6 studies had duplicate subjects, and 11 studies were not available for full text. Therefore, 21 studies were finally included for the review of this study (Fig. 1).
Study Characteristics
This systematic review and meta-analysis of 21 studies involved a total of 17843 individuals (Table 1). According to country and regional breakdown, 11 studies were conducted in the America (11 studies were all in the United States.), 2 in Asia (China, Jordan), 4 in Europe (The United Kingdom, Spain, Norway, France), one in Turkey, which spans Eurasia, and three in America and Europe (Both in the United States and Denmark).
The average number of participants in each study was 850 (range, 29 to 2541). Thirteen studies used the Pittsburgh Fatigue Rating Scale (PFS) to assess fatigue, and three studies used the Fatigue Severity Scale (FSS). The other 5 studies used Chalder Fatigue Questionnaire (CFQ), the Turkish version of Checklist Individual Strength (CIS-T), and Functional Assessment of Chronic Illness Therapy-Fatigue Scale (FACIT), The Fatigue Symptom Inventory (FSI), Visual Analogue Scales (VAS). Eight studies addressed fatigue, 12 studies addressed physical fatigability, and 6 studies addressed mental fatigability.
Table 1. Characteristics of 21 studies included in the meta-analysis
|
Study
|
Country
|
Economic level
|
Total No.of Participants
|
Average of
|
Men,No(%)
|
Assessment tool
|
Cut-off
|
No.of Participants with fatigue
|
NOS
|
age, mean(SD)
|
Glynn et al. 2022
|
USA and Denmark
|
developed country
|
2258
|
73.5(10.4)
|
1023(45.3)
|
PFS
|
PFS Physical ≥15
|
948
|
5
|
Alfini et al. 2020
|
USA
|
developed country
|
382
|
73.1(10.3)
|
179(46.9)
|
PFS
|
PFS Physical ≥15; PFS Mental ≥13
|
Physical, n=160; Mental, n=83
|
4
|
Simonsick et al. 2018
|
USA
|
developed country
|
579
|
73.6(NR)
|
271(46.8)
|
PFS
|
PFS Physical ≥15; PFS Mental ≥13
|
Physical, n=238; Mental, n=131
|
3
|
Cooper et al. 2019
|
UK
|
developed country
|
793
|
Range=68
|
337(42.3)
|
PFS
|
PFS Physical ≥15
|
412
|
5
|
Pérez et al. 2019
|
Spain
|
developed country
|
79
|
77.2(5.0)
|
19(24.1)
|
PFS
|
PFS Physical ≥15
|
63
|
3
|
Egerton et al. 2016
|
Norway
|
developed country
|
980
|
73.4(1.9)
|
509(51.9)
|
FSS
|
≥28
|
87
|
4
|
Tennant et al. 2012
|
USA
|
developed country
|
30
|
80.2(4.3)
|
7 (23.4)
|
FSS
|
≥35
|
14
|
2
|
Hu et al. 2021
|
China
|
developing country
|
457
|
84.8(5.8)
|
182(39.8)
|
PFS
|
PFS Physical ≥15
|
403
|
4
|
Banerjee et al. 2022
|
USA
|
developed country
|
48
|
68.1(9.4)
|
10(20.8)
|
FSI
|
≥ 3
|
27
|
4
|
Malak et al. 2021
|
Jordan
|
developing country
|
250
|
71.3(7.5)
|
120(48.0)
|
FACIT--Fatigue Scale
|
< 30
|
141
|
5
|
Blain et al. 2021
|
France
|
developed country
|
1471
|
Range≥65
|
485(33.0)
|
VAS
|
Female:≥5; Male ≥4
|
886
|
4
|
Cho et al. 2019
|
USA
|
developed country
|
2541
|
72.6(8.4)
|
1357(53.4)
|
CFQ
|
≥4
|
571
|
5
|
LaSorda et al. 2020
|
USA and Denmark
|
developed country
|
2355
|
73.7(10.5)
|
1066(45.3)
|
PFS
|
PFS Physical ≥15
|
992
|
5
|
Başkurt et al. 2012
|
Turkey
|
developing country
|
99
|
69.6(7.2)
|
50(50.5)
|
CIS-T
|
>76
|
54
|
2
|
Cohen et al. 2021
|
USA and Denmark
|
developed country
|
2361
|
73.6(10.5)
|
1068(45.2)
|
PFS
|
PFS Mental ≥13
|
585
|
5
|
Qiao et al. 2022
|
USA
|
developed country
|
1113
|
84.1(3.9)
|
1113(100.0)
|
PFS
|
PFS Physical ≥15; PFS Mental ≥13
|
Physical:597; Mental:247
|
5
|
Schnelle et al. 2012
|
USA
|
developed country
|
43
|
85.3(5.9)
|
NR
|
FSS
|
>4
|
16
|
3
|
Moored et al. 2021
|
USA
|
developed country
|
1672
|
84.2(4.0)
|
1672(100.0)
|
PFS
|
PFS Physical ≥15; PFS Mental ≥13
|
Physical:917; Mental:387
|
5
|
Graves et al. 2021
|
USA
|
developed country
|
181
|
71.3(6.7)
|
38(21.0)
|
PFS
|
PFS Physical ≥15
|
111
|
3
|
Wasson et al. 2019
|
USA
|
developed country
|
29
|
77.2(5.5)
|
4(13.8)
|
PFS
|
PFS Physical ≥15; PFS Mental ≥13
|
Physical: 19;
|
3
|
|
Mental: 19
|
Davis et al. 2021
|
USA
|
developed country
|
122
|
Range≥80
|
56(45.9)
|
PFS
|
PFS Physical ≥15
|
98
|
3
|
Abbreviations: CFQ, Chalder Fatigue Questionnaire; CIS-T, the Turkish version of Checklist Individual Strength; FACIT-Fatigue Scale, Functional Assessment of Chronic Illness Therapy-Fatigue Scale; FSI, Fatigue Symptom Inventory; FSS, Fatigue Severity Scale; PFS, Pittsburgh Fatigability Scale; VAS, visual analogue scales; NOS, Newcastle-Ottawa score; NR, not reported.
|
Study quality
When the Newcastle-Ottawa Quality Assessment criteria was used to score the quality of included studies (out of a total of 5 points), there were 2 studies with a score of 2, 6 studies with a score of 3, 4 studies with a score of 4, and 9 studies with a score of 5 (the scores of individual studies are shown in eTable 1 in the Supplementary Material). All included studies used validated measurement instruments with valid cutoff scores (n=21, 100.0%). On the other hand, 9 studies (42.8%) had suboptimal sample size representation. 7 studies (33.3%) had a sample size of less than 200 participants or convenience samples. In 4 studies (19.0%), the comparability between responders and non-responders was not satisfactory, or the response rate or characteristics of responders and non-responders were not described; Two studies (9.5%) did not report descriptive statistics, were incomplete or did not include appropriate dispersion measures.
Pooled and Stratified Prevalence of Fatigue in Older Adults
Based on the random effects model, the prevalence of fatigue in older adults was 42.6% (95% CI, 26.2%-59.0%). The prevalence of perceived physical fatigability was 58.2% (95% CI, 49.2%-67.2%), and the prevalence of perceived mental fatigability was 24.0% (95% CI, 21.2%-26.8%). There was significant heterogeneity among the studies. The I2 of fatigue, perceived physical fatigability and mental fatigability prevalence were 99.4%, 98.8% and 81.4%, respectively (Fig. 2).
Subgroup Analysis
To further identify the source of heterogeneity, we conducted subgroup analyses according to different characteristics of the included literature (gender, regional economic level, age, sample representativeness, sample size, comparability of respondents and non-respondents, literature quality score).
Fatigue in older adults by gender
Nine studies provided prevalence estimates by gender (Table 2). The prevalence of fatigue was 39.1% in female and 40.7% in male. The perceived physical fatigability of older adults was 60.3% in female, and the perceived mental fatigability was 26.3%. 58.8% of the male perceived physical fatigability, and 22.2% of male perceived mental fatigability. Subgroup analysis showed no significant difference between genders (p=0.460; p=0.921; p=0.123).
Fatigue in older adults by regional economic level
The results of subgroup analysis showed that for countries with different levels of economic development, the prevalence of perceived physical fatigability and general fatigue among older adults was statistically significant (Table 2). The prevalence of perceived physical fatigability was 55.3% in developed countries and 88.2% in developing countries (p < .001). The prevalence of common fatigue was 38.1% in developed countries and 55.9% in developing countries (p = 0.046).
Fatigue in older adults by age
The pooled prevalence of perceived physical fatigability was significantly different between the older age group under 80 years and the older age group 80 years and above (p = 0.033) (Table 2).
Other sources of heterogeneity: study-level characteristics
Subgroup analyses indicated that the pooled prevalence of fatigue in older adults did not significantly vary according to study-level characteristics (Table 3). This included sample representativeness (QB=0.1, p=0.751), sample size (QB=0.3, p=0.579, comparability of respondents and non-respondents (QB=1.7, p=0.195), descriptive statistics (QB=0.1, p=0.696), NOS score (QB=1.7, p=0.195).
The prevalence of perceived physical fatigability among older adults varied significantly across strata of the components of the Newcastle-Ottawa scale (Table 4). This included representability of the sample (QB=25.8, p< .001), sample size (QB=7.1, p=0.008), comparability of respondents and non-respondents (QB=13.7, p< .001), and literature quality score (QB=11.8, p=0.001).
The prevalence of perceived mental fatigue among older adults varied significantly at the level of sample representativeness (QB=22.8, p< .001) and sample size (QB=22.8, p< .001) for the components of the Newcastle-Ottawa scale (Table 5).